Ultragenyx Pharmaceutical, Inc. is a company in the U.S. stock market and it is a holding in 58 U.S.-traded ETFs. RARE has around 6.2M shares in the U.S. ETF market. The largest ETF holder of RARE is the iShares Russell 2000 ETF (IWM), with approximately 1.20M shares. Investors may also find of interest that the ETF with the largest allocation to RARE stock is First Trust NYSE Arca Biotechnology Index Fund (FBT), with a portfolio weight of 4.36%. On average, U.S. ETFs allocate 0.50% of RARE to their portfolios.
Additionally, RARE is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RARE as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 48.92%.